- CO/AI
- Posts
- Tempus AI to IPO
Tempus AI to IPO
No AI hype. No AI doom.
COAI Just actionable resources and strategies to accelerate your success in the age of AI
Today’s Story
Tempus AI, a health tech company, that provides "AI-enabled precision medicine" filed for an IPO on May 21
Founded in 2015, Tempus has developed the world's largest library of clinical and molecular data and an operating system for precision medicine.
They focus on AI-enabled diagnostics and personalized medicine across various fields including cancer, cardiology, neuropsychology, and radiology.
Tempus aims to create "Intelligent Diagnostics" using AI to enhance laboratory tests.
Its services are already utilized by 95% of the largest public pharmaceutical companies and over 7,000 physicians.
The COAI Digest
Research
AI and the Future of Expertise
How Artificial Intelligence Could Reshape the Labor Market and Restore the Middle Class
While many are understandably anxious about the impact of AI on jobs, there is a compelling case that “AI will change the labor market, but not in the way Musk and Hinton believe.
Instead, it could “reshape the value and nature of human expertise” itself
Tool Spotlight
AJELIX: An AI-powered tool designed to enhance productivity and efficiency when working with Excel and Google Sheets, offering features such as AI formula generation, formula explanation, VBA script generation
Reply